Evidence map›Paper›PMID 23970016›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2013

Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4).

C Bosetti, E Lucenteforte, P M Bracci, E Negri, R E Neale, H A Risch, S H Olson, S Gallinger, A B Miller, H B Bueno-de-Mesquita and 16 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Global trends in pancreas cancer among Asia-Pacific population.Journal of gastrointestinal oncology · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 8 countries.

C BosettiDepartment of Epidemiology, IRCCS, Istituto di Ricerche Farmacologiche 'Mario Negri', Milan.
E Lucenteforte
P M Bracci
E Negri
R E Neale
H A Risch
S H Olson
S Gallinger
A B Miller
H B Bueno-de-Mesquita
R Talamini
J Polesel
P Ghadirian
P A Baghurst
W Zatonski
E Fontham
E A Holly
Y T Gao
H Yu
R C Kurtz
M Cotterchio
P Maisonneuve
M P Zeegers
E J Duell
P Boffetta
C La Vecchia
Centro di Riferimento Oncologico · ITMario Negri Institute for Pharmacological Research · ITMemorial Sloan Kettering Cancer Center · USUniversity of California, San Francisco · USCancer Center of Hawaii · USEuropean Institute of Oncology · ITInstitut Català d'Oncologia · ESInternational Prevention Research Institute · FRLouisiana State University · USMaastricht University Medical Centre · NLNational Institute for Public Health and the Environment · NLPublic Health Ontario · CAQIMR Berghofer Medical Research Institute · AUShanghai Cancer Institute · CNToronto General Hospital · CAUniversity of Florence · ITUniversity of Milan · ITUniversity of Toronto · CAWomen's and Children's Hospital · AUYale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)R01CA097075 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2002 to 2012
$15.8M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
Case-Control Study of Pancreas Cancer Etiologic FactorsR01CA098870 · NCI · YALE UNIVERSITY · PI RISCH, HARVEY A · 2003 to 2008
$3.5M
Molecular Epidemiology of Pancreatic CancerR01CA109767 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRACCI, PAIGE M. · 2005 to 2010
$3.2M
DNA Repair Gene Polymorphysms and Pancreatic CancerR01CA098889 · NCI · DARTMOUTH COLLEGE · PI DUELL, ERIC J · 2003 to 2005
$793k
Pancreas cancer analysis-SF Bay Area case-control studyR03CA108370 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2004 to 2005
$152k
MTHFR POLYMORPHISMS IN PANCREATIC CANCER IN SF BAY AREAR03CA089726 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2002
$148k
PANCREATIC CANCER CASE CONTROL STUDY IN SAN FRANCISCOR01CA059706 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 1994 to 1998
–
NCI NIH HHS 5R01-CA098870NCI NIH HHS CA098889NCI NIH HHS CA108370NCI NIH HHS CA109767NCI NIH HHS CA59706NCI NIH HHS CA89726NCI NIH HHS N01-PC-35136NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA97075NCI NIH HHS U01 CA074783NCI NIH HHS U01-CA74783NCI NIH HHS UM1 CA186107
6 · The paper itself

Abstract

backgroundPeptic ulcer and its treatments have been associated to pancreatic cancer risk, although the evidence is inconsistent.

methodsWe pooled 10 case-control studies within the Pancreatic Cancer Case-control Consortium (PanC4), including 4717 pancreatic cancer cases and 9374 controls, and estimated summary odds ratios (OR) using multivariable logistic regression models.

resultsThe OR for pancreatic cancer was 1.10 [95% confidence interval (CI) 0.98-1.23] for history of ulcer (OR = 1.08 for gastric and 0.97 for duodenal ulcer). The association was stronger for a diagnosis within 2 years before cancer diagnosis (OR = 2.43 for peptic, 1.75 for gastric, and 1.98 for duodenal ulcer). The OR was 1.53 (95% CI 1.15-2.03) for history of gastrectomy; however, the excess risk was limited to a gastrectomy within 2 years before cancer diagnosis (OR = 6.18, 95% CI 1.82-20.96), while no significant increased risk was observed for longer time since gastrectomy. No associations were observed for pharmacological treatments for ulcer, such as antacids, H2-receptor antagonists, or proton-pump inhibitors.

conclusionsThis uniquely large collaborative study does not support the hypothesis that peptic ulcer and its treatment materially affect pancreatic cancer risk. The increased risk for short-term history of ulcer and gastrectomy suggests that any such association is due to increased cancer surveillance.

Indexed as

AgedCase-Control StudiesFemaleGastrectomyGastrointestinal DiseasesHumansLogistic ModelsMiddle AgedPancreatic NeoplasmsRisk FactorsUlceranti-ulcer drugscase–control studygastrectomypancreatic cancerpeptic ulcerpooled analysis

Identifiers

PMID23970016
PMCPMC3811904
OpenAlexW2117085599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.